Page last updated: 2024-09-03

20-hydroxy-5,8,11,14-eicosatetraenoic acid and vapiprost

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with vapiprost in 1 studies

Compound Research Comparison

Studies
(20-hydroxy-5,8,11,14-eicosatetraenoic acid)
Trials
(20-hydroxy-5,8,11,14-eicosatetraenoic acid)
Recent Studies (post-2010)
(20-hydroxy-5,8,11,14-eicosatetraenoic acid)
Studies
(vapiprost)
Trials
(vapiprost)
Recent Studies (post-2010) (vapiprost)
64013233129172

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benzoni, D; Bernard, N; Messer-Létienne, I; Roman, RJ; Sassard, J1

Other Studies

1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and vapiprost

ArticleYear
20-Hydroxyeicosatetraenoic acid and renal function in Lyon hypertensive rats.
    European journal of pharmacology, 1999, Aug-13, Volume: 378, Issue:3

    Topics: Animals; Biphenyl Compounds; Blood Pressure; Body Weight; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Fatty Acids, Unsaturated; Heptanoic Acids; Hydroxyeicosatetraenoic Acids; Hypertension; In Vitro Techniques; Kidney; Male; Miconazole; Organ Size; Oxygenases; Rats; Receptors, Thromboxane; Renal Circulation; Systole; Vascular Resistance; Vasodilation

1999